Collegium to Present at Upcoming Investor Conference
The Cantor Global Healthcare Conferenceon Tuesday, October 2nd at 2:50 p.m. ETin New York City
Collegium is a specialty pharmaceutical company focused on becoming the leader in responsible pain management by developing and commercializing innovative and differentiated products for people suffering from pain and our communities.
About Xtampza ER
Xtampza® ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the